Literature DB >> 7651382

Stable expression of a functional rat angiotensin II (AT1A) receptor in CHO-K1 cells: rapid desensitization by angiotensin II.

T J Thekkumkara1, J Du, D E Dostal, T J Motel, W G Thomas, K M Baker.   

Abstract

The octapeptide angiotensin II mediates the physiological actions of the renin-angiotensin system through activation of several angiotensin II receptor subtypes; in particular the AT1. In many tissues, the presence of multiple angiotensin II receptor subtypes, together with a low number of receptors, makes it difficult to study biological responses to physiological concentrations (10(-11)-10(-9) M) of angiotensin II. Also, cultured cells show diminished angiotensin II receptor binding with respect to time in culture and passage number. To address these problems, we expressed the recombinant AT1A receptor in CHO-K1 cells. The stably transfected receptor was characterized using radioligand binding studies and functional coupling to cytosolic free calcium. Radioligand binding of [125I] angiotensin II to the angiotensin II receptor was specific, saturable, reversible and modulated by guanine nucleotides. Like the endogenous AT1A receptor, reported in a variety of tissues, the specific, noncompetitive, nonpeptide AII receptor antagonist, EXP3174, blocked binding of [125I] angiotensin II to the transfected receptor. Scatchard analysis demonstrated that the transfected receptor had a dissociation constant of 1.9 nM with a density of 3.4 pmol/mg protein. An important feature of many of the responses to angiotensin II is the rapid desensitization that occurs following agonist occupancy and the development of tachyphylaxis. In AT1A receptor transfected CHO-K1 cells, angiotensin II (10(-9) M) stimulated a rapid increase in cytosolic free calcium that was completely desensitized within 50 sec following receptor occupancy. Agonist induced desensitization was unaffected when receptor internalization was blocked by pretreatment with concanavalin A or incubation at 4 degrees C, and no changes in AT1A receptor affinity or number were observed. Receptor desensitization was also unaffected by inhibition or activation of protein kinase C. Thus, we have established a permanent, high-level transfectant of the AT1A receptor in CHO-K1 cells and have shown that these receptors rapidly desensitize following exposure to physiological concentrations of agonist. The mechanism of rapid desensitization is not related to receptor sequestration, internalization or controlled by PKC phosphorylation. This provides an excellent model for studying AII actions mediated through a specific receptor subtype, at subnanomolar concentrations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651382     DOI: 10.1007/bf00926885

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  25 in total

1.  Use of alternative polyadenylation sites for tissue-specific transcription of two angiotensin-converting enzyme mRNAs.

Authors:  T J Thekkumkara; W Livingston; R S Kumar; G C Sen
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

2.  Role of acidic amino acids in peptide substrates of the beta-adrenergic receptor kinase and rhodopsin kinase.

Authors:  J J Onorato; K Palczewski; J W Regan; M G Caron; R J Lefkowitz; J L Benovic
Journal:  Biochemistry       Date:  1991-05-28       Impact factor: 3.162

3.  The mRNAs encoding the two angiotensin-converting isozymes are transcribed from the same gene by a tissue-specific choice of alternative transcription initiation sites.

Authors:  R S Kumar; T J Thekkumkara; G C Sen
Journal:  J Biol Chem       Date:  1991-02-25       Impact factor: 5.157

4.  Role of Na+ and protein kinase C in angiotensin desensitization and tachyphylaxis in the guinea-pig ileum.

Authors:  S I Shimuta; C A Kanashiro; A T Ferreira; M E Oshiro; T B Paiva; A C Paiva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-04       Impact factor: 3.000

5.  Angiotensin II receptor-mediated stimulation of cytosolic-free calcium and inositol phosphates in chick myocytes.

Authors:  K M Baker; H A Singer; J F Aceto
Journal:  J Pharmacol Exp Ther       Date:  1989-11       Impact factor: 4.030

6.  Identification of two subtypes in the rat type I angiotensin II receptor.

Authors:  N Iwai; T Inagami
Journal:  FEBS Lett       Date:  1992-02-24       Impact factor: 4.124

7.  Desensitization of endogenous angiotensin II receptors in Xenopus oocytes: a role of protein kinase C.

Authors:  H Sakuta; M Sekiguchi; K Okamoto; Y Sakai
Journal:  Eur J Pharmacol       Date:  1991-09-12       Impact factor: 4.432

8.  Angiotensin-induced desensitization of the phosphoinositide pathway in cardiac cells occurs at the level of the receptor.

Authors:  M M Abdellatif; C F Neubauer; W J Lederer; T B Rogers
Journal:  Circ Res       Date:  1991-09       Impact factor: 17.367

9.  Isolation and expression of a novel angiotensin II receptor from Xenopus laevis heart.

Authors:  D J Bergsma; C Ellis; P R Nuthulaganti; P Nambi; K Scaife; C Kumar; N Aiyar
Journal:  Mol Pharmacol       Date:  1993-08       Impact factor: 4.436

10.  Sites in the third intracellular loop of the alpha 2A-adrenergic receptor confer short term agonist-promoted desensitization. Evidence for a receptor kinase-mediated mechanism.

Authors:  S B Liggett; J Ostrowski; L C Chesnut; H Kurose; J R Raymond; M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

View more
  11 in total

1.  Evidence for involvement of 3'-untranslated region in determining angiotensin II receptor coupling specificity to G-protein.

Authors:  Thomas J Thekkumkara; Stuart L Linas
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

Review 2.  Angiotensin and calcium signaling in the pituitary and hypothalamus.

Authors:  Cecilia Suárez; Isabel García Tornadú; Carolina Cristina; Jorge Vela; Arturo González Iglesias; Carlos Libertun; Graciela Díaz-Torga; Damasia Becu-Villalobos
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

3.  Functional role of sodium glucose transporter in high glucose-mediated angiotensin type 1 receptor downregulation in human proximal tubule cells.

Authors:  Rekha Yesudas; Russell Snyder; Thomas Abbruscato; Thomas Thekkumkara
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-30

4.  Angiotensin II-mediated microvascular thrombosis.

Authors:  Elena Y Senchenkova; Janice Russell; Lidiana D Almeida-Paula; Joseph W Harding; D Neil Granger
Journal:  Hypertension       Date:  2010-10-25       Impact factor: 10.190

5.  Functional role for the angiotensin II receptor (AT1A) 3'-untranslated region in determining cellular responses to agonist: evidence for recognition by RNA binding proteins.

Authors:  T J Thekkumkara; W G Thomas; T J Motel; K M Baker
Journal:  Biochem J       Date:  1998-01-15       Impact factor: 3.857

6.  Angiotensin II stimulates rapid serine phosphorylation of transcription factor Stat3.

Authors:  G J Bhat; K M Baker
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

7.  Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts.

Authors:  W R Ford; A S Clanachan; C R Hiley; B I Jugdutt
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

8.  Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor.

Authors:  H Qian; L Pipolo; W G Thomas
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

9.  The trafficking protein GABARAP binds to and enhances plasma membrane expression and function of the angiotensin II type 1 receptor.

Authors:  Julia L Cook; Richard N Re; Dawn L deHaro; Jennifer M Abadie; Michelle Peters; Jawed Alam
Journal:  Circ Res       Date:  2008-05-22       Impact factor: 17.367

10.  Expression and distribution of NADPH oxidase isoforms in human myometrium--role in angiotensin II-induced hypertrophy.

Authors:  Xiao-Lan Cui; Baojun Chang; Leslie Myatt
Journal:  Biol Reprod       Date:  2009-10-07       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.